Emergency department-based efforts to offer medication treatment for opioid use disorder: What can we learn from current approaches?

J Subst Abuse Treat. 2021 Oct:129:108479. doi: 10.1016/j.jsat.2021.108479. Epub 2021 May 15.

Abstract

Background: The opioid epidemic remains a public health crisis and most people with opioid use disorder (OUD) do not receive effective treatment. The emergency department (ED) can be a critical entry point for treatment. EDs are developing and implementing ED-based efforts to address OUD to improve access to OUD treatment. This study's objective is to identify features of ED-based OUD treatment programs that relate to program implementation, effectiveness, and sustainability.

Methods: We obtained data through literature review and semistructured interviews with ED physicians and leaders. The study analyzed these data to develop a framework of key components of ED-based efforts and highlight barriers and facilitators to implementation and program effectiveness.

Results: We identify five key features of ED-based opioid treatment programs that vary across programs and may influence effectiveness and impact: patient identification methods; treatment approaches; program structure; relationship with community partners; and financing and sustainability. Successful implementation of ED-based OUD treatment includes having a champion, a reliable referral network, and systematic tracking and reporting of data for monitoring and feedback.

Conclusion: Going forward, attention to these features may help to improve effectiveness. As researchers conduct studies of ED-based care models, they should assess the impact of variation in key features to improve program effectiveness.

Keywords: Emergency department; Medication for addiction treatment; Opioid use disorder.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Analgesics, Opioid / therapeutic use
  • Buprenorphine* / therapeutic use
  • Emergency Service, Hospital
  • Humans
  • Opioid-Related Disorders* / drug therapy
  • Referral and Consultation

Substances

  • Analgesics, Opioid
  • Buprenorphine